MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Summary

The purpose of this Cohort Treatment Plan is to allow access to ruxolitinib for eligible patients diagnosed with Polycythemia Vera. The patient's Treating Physician should follow the suggested treatment guidelines and comply with all local health authority regulations.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications